Eucrates Biomedical Acqui... (EUCR)
NASDAQ: EUCR
· Real-Time Price · USD
10.04
0.00 (0.00%)
At close: Apr 26, 2023, 9:14 PM
Eucrates Biomedical Acquisition Revenue
Eucrates Biomedical Acquisition reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2022, Eucrates Biomedical Acquisition generated $0 in revenue.
Revenue (ttm)
0
Revenue Growth
n/a
Price / Sales Ratio
0
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2022 | 0 | n/a |
Dec 31, 2021 | 0 | n/a |
Dec 31, 2020 | 0 | n/a |